CytoMed Therapeutics Ltd (GDTC)
2.11
-0.02
(-0.94%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
After-Hours: 19:52
CytoMed Therapeutics Cash from Financing (TTM): 8.153M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.153M |
| June 30, 2023 | 8.925M |
| December 31, 2022 | 0.6987M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.1235M |
| December 31, 2021 | 3.128M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.1235M
Minimum
Jun 2022
8.925M
Maximum
Jun 2023
4.206M
Average
3.128M
Median
Dec 2021